Balance Sheet Information

6 Months Ended

Jun. 30, 2011

Balance Sheet Information [Abstract]

Balance Sheet Information

Note 4 — Balance Sheet Information

     The following tables provide details of selected balance sheet line items as of June 30, 2011 and December 31, 2010 (in thousands):

Inventories

	June 30,		December 31,
	2011		2010
Raw materials and supplies	$	19,835	$	16,915
Work in process		24,338		21,446
Finished goods		26,493		28,055
Inventories	$	70,666	$	66,416

Property, Plant and Equipment, Net

	June 30,			December 31,
	2011			2010
Land	$	19,367		$	19,287
Building		80,085			80,010
Machinery and equipment		208,915			195,927
Building improvements		55,529			48,217
Furniture and fixtures		20,869			21,999
Construction in-progress		195			1,855
Property, plant and equipment, at cost		384,960			367,295
Less: accumulated depreciation and amortization		(215,698	)		(206,432	)
Property, plant and equipment, net	$	169,262		$	160,863

Purchased Intangibles, Net

	June 30,			December 31,
	2011			2010
Purchased intangibles, at cost	$	167,223		$	166,541
Less: accumulated amortization		(51,217	)		(46,271	)
Purchased intangibles, net	$	116,006		$	120,270

License, Manufacturing Access Fees and Other Assets, Net

	June 30,			December 31,
	2011			2010
License and manufacturing access fees	$	67,905		$	64,259
Investment in Qualigen, Inc.		5,404			5,404
Investment in DiagnoCure, Inc.		5,000			5,000
Investment in Roka Bioscience, Inc.		4,705			725
Other assets		11,565			8,782
License, manufacturing access fees and other assets, at cost		94,579			84,170
Less: accumulated amortization		(29,016	)		(23,995	)
License, manufacturing access fees and other assets, net	$	65,563		$	60,175

Other Accrued Expenses

	June 30,		December 31,
	2011		2010
Royalties	$	4,445	$	3,315
Research and development		3,230		3,385
Professional fees		1,740		1,182
Marketing		704		1,177
Warranty		207		373
Interest		162		896
Other		3,451		3,607
Other accrued expenses	$	13,939	$	13,935